Michael Gould to Middle Aged
This is a "connection" page, showing publications Michael Gould has written about Middle Aged.
Connection Strength
2.009
-
Effect of a Community-Based Medical Oncology Depression Screening Program on Behavioral Health Referrals Among Patients With Breast Cancer: A Randomized Clinical Trial. JAMA. 2022 01 04; 327(1):41-49.
Score: 0.087
-
Identifying patients with symptoms suspicious for COVID-19 at elevated risk of adverse events: The COVAS score. Am J Emerg Med. 2021 Aug; 46:489-494.
Score: 0.080
-
Early identification of COVID-19 cytokine storm and treatment with anakinra or tocilizumab. Int J Infect Dis. 2020 Oct; 99:291-297.
Score: 0.079
-
Monitoring Lung Cancer Screening Use and Outcomes at Four Cancer Research Network Sites. Ann Am Thorac Soc. 2017 Dec; 14(12):1827-1835.
Score: 0.065
-
Comorbidity Profiles and Their Effect on Treatment Selection and Survival among Patients with Lung Cancer. Ann Am Thorac Soc. 2017 Oct; 14(10):1571-1580.
Score: 0.064
-
Implementation of the Canadian CT Head Rule and Its Association With Use of Computed Tomography Among Patients With Head Injury. Ann Emerg Med. 2018 Jan; 71(1):54-63.e2.
Score: 0.064
-
Anxiety, Culture, and Expectations: Oncologist-Perceived Factors Associated With Use of Nonrecommended Serum Tumor Marker Tests for Surveillance of Early-Stage Breast Cancer. J Oncol Pract. 2017 01; 13(1):e77-e90.
Score: 0.061
-
Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial. Ann Am Thorac Soc. 2016 09; 13(9):1568-74.
Score: 0.060
-
CURB-65 Performance Among Admitted and Discharged Emergency Department Patients With Community-acquired Pneumonia. Acad Emerg Med. 2016 Apr; 23(4):400-5.
Score: 0.058
-
Brain Imaging for Staging of Patients With Clinical Stage IA Non-small Cell Lung Cancer in the National Lung Screening Trial: Adherence With Recommendations From the Choosing Wisely Campaign. Chest. 2016 Apr; 149(4):943-50.
Score: 0.057
-
Survival among Never-Smokers with Lung Cancer in the Cancer Care Outcomes Research and Surveillance Study. Ann Am Thorac Soc. 2016 Jan; 13(1):58-66.
Score: 0.057
-
Use of posttreatment imaging and biomarkers in survivors of early-stage breast cancer: Inappropriate surveillance or necessary care? Cancer. 2016 Mar 15; 122(6):908-16.
Score: 0.057
-
Recent Trends in the Identification of Incidental Pulmonary Nodules. Am J Respir Crit Care Med. 2015 Nov 15; 192(10):1208-14.
Score: 0.057
-
An Age-Adjusted D-dimer Threshold for Emergency Department Patients With Suspected Pulmonary Embolus: Accuracy and Clinical Implications. Ann Emerg Med. 2016 Feb; 67(2):249-57.
Score: 0.056
-
Use of imaging for staging of early-stage breast cancer in two integrated health care systems: adherence with a choosing wisely recommendation. J Oncol Pract. 2015 May; 11(3):e320-8.
Score: 0.054
-
Clinical practice. Lung-cancer screening with low-dose computed tomography. N Engl J Med. 2014 Nov 06; 371(19):1813-20.
Score: 0.053
-
Facility-level analysis of PET scanning for staging among US veterans with non-small cell lung cancer. Chest. 2014 Apr; 145(4):839-847.
Score: 0.051
-
Facility characteristics and quality of lung cancer care in an integrated health care system. J Thorac Oncol. 2014 Apr; 9(4):447-55.
Score: 0.051
-
Predicting in-hospital mortality among critically ill patients with end-stage liver disease. J Crit Care. 2012 Dec; 27(6):740.e1-7.
Score: 0.046
-
Automated identification of patients with pulmonary nodules in an integrated health system using administrative health plan data, radiology reports, and natural language processing. J Thorac Oncol. 2012 Aug; 7(8):1257-62.
Score: 0.045
-
Disparities in lung cancer staging with positron emission tomography in the Cancer Care Outcomes Research and Surveillance (CanCORS) study. J Thorac Oncol. 2011 May; 6(5):875-83.
Score: 0.041
-
Validation of two models to estimate the probability of malignancy in patients with solitary pulmonary nodules. Thorax. 2008 Apr; 63(4):335-41.
Score: 0.032
-
A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest. 2007 Feb; 131(2):383-8.
Score: 0.031
-
A clinical prediction rule to estimate the probability of mediastinal metastasis in patients with non-small cell lung cancer. J Thorac Oncol. 2006 Nov; 1(9):953-9.
Score: 0.030
-
Variability in the use of thromboprophylaxis and outcomes in critically ill medical patients. Am J Med. 2005 Dec; 118(12):1373-80.
Score: 0.028
-
Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax. 2005 Jul; 60(7):588-94.
Score: 0.028
-
Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax. 2005 Nov; 60(11):949-55.
Score: 0.028
-
Outcomes in critically ill patients before and after the implementation of an evidence-based nutritional management protocol. Chest. 2004 Apr; 125(4):1446-57.
Score: 0.025
-
Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003 Dec 02; 139(11):879-92.
Score: 0.025
-
Variability in antibiotic prescribing patterns and outcomes in patients with clinically suspected ventilator-associated pneumonia. Chest. 2003 Mar; 123(3):835-44.
Score: 0.023
-
Women with spinal cord injury and the impact of aging. Spinal Cord. 2002 Aug; 40(8):374-87.
Score: 0.023
-
A Patient Portal-Based Commitment Device to Improve Adherence with Screening for Colorectal Cancer: a Retrospective Observational Study. J Gen Intern Med. 2021 04; 36(4):952-960.
Score: 0.020
-
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824 650 Patients With Hypertension From a US Integrated Healthcare System. J Am Heart Assoc. 2021 02 02; 10(3):e019669.
Score: 0.020
-
Risk models for VTE and bleeding in medical inpatients: systematic identification and expert assessment. Blood Adv. 2020 06 23; 4(12):2557-2566.
Score: 0.019
-
Prognostic factors for VTE and bleeding in hospitalized medical patients: a systematic review and meta-analysis. Blood. 2020 05 14; 135(20):1788-1810.
Score: 0.019
-
Effect of Physical Activity Coaching on Acute Care and Survival Among Patients With Chronic Obstructive Pulmonary Disease: A Pragmatic Randomized Clinical Trial. JAMA Netw Open. 2019 08 02; 2(8):e199657.
Score: 0.018
-
Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med. 1999 May 18; 130(10):789-99.
Score: 0.018
-
Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty. J Arthroplasty. 2017 11; 32(11):3524-3528.e1.
Score: 0.016
-
Physician Assessment of Pretest Probability of Malignancy and Adherence With Guidelines for Pulmonary Nodule Evaluation. Chest. 2017 08; 152(2):263-270.
Score: 0.015
-
Longitudinal Changes in Depression Symptoms and Survival Among Patients With Lung Cancer: A National Cohort Assessment. J Clin Oncol. 2016 11 20; 34(33):3984-3991.
Score: 0.015
-
Deploying Team Science Principles to Optimize Interdisciplinary Lung Cancer Care Delivery: Avoiding the Long and Winding Road to Optimal Care. J Oncol Pract. 2016 11; 12(11):983-991.
Score: 0.015
-
Depression symptom trends and health domains among lung cancer patients in the CanCORS study. Lung Cancer. 2016 10; 100:102-109.
Score: 0.015
-
Safe and Effective Implementation of Telestroke in a US Community Hospital Setting. Perm J. 2016; 20(4):15-217.
Score: 0.015
-
Use of [(18)F]Fluoro-2-deoxy-d-glucose Positron Emission Tomographic Imaging in the National Lung Screening Trial. Chest. 2016 09; 150(3):621-30.
Score: 0.015
-
The Online Personal Action Plan: A Tool to Transform Patient-Enabled Preventive and Chronic Care. Am J Prev Med. 2016 07; 51(1):71-7.
Score: 0.014
-
Management of Pulmonary Nodules by Community Pulmonologists: A Multicenter Observational Study. Chest. 2015 Dec; 148(6):1405-1414.
Score: 0.014
-
Lung cancer screening. Am J Respir Crit Care Med. 2015 Jan 01; 191(1):19-33.
Score: 0.013
-
Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients. JAMA. 2014 Nov 26; 312(20):2135-45.
Score: 0.013
-
Resource use and guideline concordance in evaluation of pulmonary nodules for cancer: too much and too little care. JAMA Intern Med. 2014 Jun; 174(6):871-80.
Score: 0.013
-
The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest. 2014 Mar 01; 145(3):464-472.
Score: 0.013
-
Patient preference and contraindications in measuring quality of care: what do administrative data miss? J Clin Oncol. 2013 Jul 20; 31(21):2716-23.
Score: 0.012
-
The accuracy and trends of smoking history documentation in electronic medical records in a large managed care organization. Subst Use Misuse. 2013 Jun; 48(9):731-42.
Score: 0.012
-
What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest. 2013 Mar; 143(3):672-677.
Score: 0.012
-
'The thing is not knowing': patients' perspectives on surveillance of an indeterminate pulmonary nodule. Health Expect. 2015 Jun; 18(3):355-65.
Score: 0.012
-
Sociodemographic characteristics of members of a large, integrated health care system: comparison with US Census Bureau data. Perm J. 2012; 16(3):37-41.
Score: 0.011
-
Lung cancer stage at diagnosis: Individual associations in the prospective VITamins and lifestyle (VITAL) cohort. BMC Cancer. 2011 Jun 07; 11:228.
Score: 0.010
-
Length of stay predictions: improvements through the use of automated laboratory and comorbidity variables. Med Care. 2010 Aug; 48(8):739-44.
Score: 0.010
-
PET scan 18F-fluorodeoxyglucose uptake and prognosis in patients with resected clinical stage IA non-small cell lung cancer. Chest. 2010 May; 137(5):1150-6.
Score: 0.009
-
Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl. 2009 Aug; 15(8):894-906.
Score: 0.009
-
Impact of the lung allocation score on lung transplantation for pulmonary arterial hypertension. Am J Respir Crit Care Med. 2009 Sep 01; 180(5):468-74.
Score: 0.009
-
Identification of early acute lung injury at initial evaluation in an acute care setting prior to the onset of respiratory failure. Chest. 2009 Apr; 135(4):936-943.
Score: 0.009
-
Asthma control, severity, and quality of life: quantifying the effect of uncontrolled disease. J Allergy Clin Immunol. 2007 Aug; 120(2):396-402.
Score: 0.008
-
Lung cancer incidence in never smokers. J Clin Oncol. 2007 Feb 10; 25(5):472-8.
Score: 0.008
-
Clinical and demographic predictors of long-term disability in patients with relapsing-remitting multiple sclerosis: a systematic review. Arch Neurol. 2006 Dec; 63(12):1686-91.
Score: 0.008
-
Computed tomography of abdominal carcinoid tumour. Br J Radiol. 1986 Sep; 59(705):881-5.
Score: 0.007
-
Meta-analysis: accuracy of quantitative ultrasound for identifying patients with osteoporosis. Ann Intern Med. 2006 Jun 06; 144(11):832-41.
Score: 0.007
-
Patients' perspectives on how idiopathic pulmonary fibrosis affects the quality of their lives. Health Qual Life Outcomes. 2005 Oct 07; 3:61.
Score: 0.007
-
Determinants of health utility in lung and heart-lung transplant recipients. Am J Transplant. 2005 Jan; 5(1):103-9.
Score: 0.007
-
Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation: Guidelines on colon cancer screening. Can J Gastroenterol. 2004 Feb; 18(2):93-9.
Score: 0.006
-
Occupational inhalant exposure and respiratory disorders among never-smokers referred to a hospital pulmonary function laboratory. Am J Med Sci. 2001 Sep; 322(3):121-6.
Score: 0.005
-
Promoting physical activity in general practice: should prescribed exercise be free? J R Soc Med. 1999 Feb; 92(2):65-7.
Score: 0.004
-
Life-threatening complication of minimally invasive coronary artery bypass grafting. Acad Emerg Med. 1998 Jul; 5(7):746-7.
Score: 0.004
-
The angiotensin-converting enzyme gene and the angiotensin II type I receptor gene as candidate genes for microalbuminuria. A study in nondiabetic and non-insulin-dependent diabetic subjects. Arterioscler Thromb Vasc Biol. 1997 Oct; 17(10):2188-91.
Score: 0.004
-
Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicity. Blood. 1995 Nov 01; 86(9):3287-94.
Score: 0.004